This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Chapman, J Articles by Shoenfeld, Y Search for Related Content PubMed PubMed Citation Articles by Chapman, J Articles by Shoenfeld, Y Social Bookmarking                         What's this?

Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies

Department of Neurology, Sheba Medical Center, Tel Hashomer 52621, Israel, jchapman{at}post.tau.ac.il

J H Rand

Thrombosis and Hemostasis Section, Hematology Division, Mount Sinai School of Medicine, New York, USA

R L Brey

Division of Neurology, University of Texas Health Science Center at San Antonio, Texas, USA

S R Levine

Department of Neurology, The Mount Sinai School of Medicine, New York, USA

I Blatt

Department of Neurology, Sheba Medical Center, Tel Hashomer 52621, Israel

M A Khamashta

Center for Autoimmune Diseases, Chaim Sheba Medical Center, Tel-Hashomer, Israel

Y Shoenfeld

Lupus Unit, The Rayne Institute, St. Thomas Hospital, London, UK

Although many types of neurological disorders and events have been described in association with antiphospholipidantibodies(aPL) and the antiphospholipidsyndrome (APS), only ischaemic stroke is reasonably well established and accepted as a diagnostic criterion for the syndrome. We propose to evaluate, classify and rank the association of other neurological manifestations as possible, probable, or definite according to the data available from clinical studies and animal models. By these criteria, none of the neurologicaldisordersor events such as epilepsy, psychiatricdisease, dementia, transverse myelitis, multiple sclerosis-like disease, chorea, migraine, Guillian-Barrèsyndrome, and sensory-neural hearing loss, can be definitely associated with aPL or APS.

Key Words: antiphospholipid antibodies • cerebrovascular disease • chorea • dementia • epilepsy • migraine • multiple sclerosis

Lupus, Vol. 12, No. 7, 514-517 (2003)
DOI: 10.1191/0961203303lu392oa


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				T. Avcin, R. Cimaz, E. D. Silverman, R. Cervera, M. Gattorno, S. Garay, Y. Berkun, F. R. Sztajnbok, C. A. Silva, L. M. Campos, et al. Pediatric Antiphospholipid Syndrome: Clinical and Immunologic Features of 121 Patients in an International Registry Pediatrics, November 1, 2008; 122(5): e1100 - e1107. [Abstract] [Full Text] [PDF]

				H. Raza, S. A. Epstein, M. Pao, and D. L. Rosenstein Mania: Psychiatric Manifestations of the Antiphospholipid Syndrome Psychosomatics, September 1, 2008; 49(5): 438 - 441. [Abstract] [Full Text] [PDF]

				T. Avcin and E. Silverman Review: Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome Lupus, August 1, 2007; 16(8): 627 - 633. [Abstract] [PDF]

				I Krause, L Leibovici, M Blank, and Y Shoenfeld Clusters of disease manifestations in patients with antiphospholipid syndrome demonstrated by factor analysis Lupus, March 1, 2007; 16(3): 176 - 180. [Abstract] [PDF]

				M. Blank, I. Krause, L. Magrini, G. Spina, J. Kalil, S. Jacobsen, H. J. Thiesen, M. W. Cunningham, L. Guilherme, and Y. Shoenfeld Overlapping humoral autoimmunity links rheumatic fever and the antiphospholipid syndrome Rheumatology, July 1, 2006; 45(7): 833 - 841. [Abstract] [Full Text] [PDF]

				L. Statkute, A. Traynor, Y. Oyama, K. Yaung, L. Verda, N. Krosnjar, and R. K. Burt Antiphospholipid syndrome in patients with systemic lupus erythematosus treated by autologous hematopoietic stem cell transplantation Blood, October 15, 2005; 106(8): 2700 - 2709. [Abstract] [Full Text] [PDF]

				I Krause, S Lev, A Fraser, M Blank, M Lorber, L Stojanovich, J Rovensky, J Chapman, and Y Shoenfeld Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndrome Ann Rheum Dis, October 1, 2005; 64(10): 1490 - 1493. [Abstract] [Full Text] [PDF]

				J. Vilisaar, M. Wilson, G. Niepel, L. D Blumhardt, and C. S Constantinescu A comparative audit of anticardiolipin antibodies in oligoclonal band negative and positive multiple sclerosis Multiple Sclerosis, August 1, 2005; 11(4): 378 - 380. [Abstract] [PDF]

				J. A. Gomez-Puerta, R. Cervera, L. M. Calvo, B. Gomez-Anson, G. Espinosa, G. Claver, S. Bucciarelli, A. Bove, M. Ramos-Casals, M. Ingelmo, et al. Dementia associated with the antiphospholipid syndrome: clinical and radiological characteristics of 30 patients Rheumatology, January 1, 2005; 44(1): 95 - 99. [Abstract] [Full Text] [PDF]

				F Neri, L Chimini, F Bonomi, E Filippini, M Motta, D Faden, A Lojacono, C B. Rebaioli, M Frassi, E Danieli, et al. Neuropsychological development of children born to patients with systemic lupus erythematosus Lupus, October 1, 2004; 13(10): 805 - 811. [Abstract] [PDF]